Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Acid-stable Protease Inhibitor
2. Miraclid
3. Mr 20
4. Mr 20 (magnetic Powder) Of Urinastatin
5. Mr-20 (magnetic Powder)
6. Trypsin Inhibitor Mr-20
7. Ulinastatin
8. Urinary Trypsin Inhibitor
9. Urinary Trypsin Inhibitor (68)
10. Urinary Trypsin Inhibitor-like Inhibitor (43)
11. Urinastatin
12. Uti(68)
13. Uti68
1. 80499-32-7
2. 80449-32-7
3. 3-(furan-2-yl)-2,4-dioxaspiro[5.5]undec-8-ene
4. Trypsin Inhibitor (human Urine Urinastatin Protein Moiety)
5. 3-(furan-2-yl)-2,4-dioxaspiro[5.5]undec-9-ene
6. 2,4-dioxaspiro(5.5)undec-8-ene, 3-(2-furanyl)-
7. Trypsin Inhibitor Mr-20
8. Mr-20 (magnetic Powder)
9. Uti(68)
10. Acid-stable Protease Inhibitor
11. Urinary Trypsin Inhibitor (68)
12. Mr 20
13. Unii-or3s9if86u
14. Uristatin
15. Mingin
16. Urinary Trypsin Inhibitor-like Inhibitor (43)
17. Trypsin Inhibitor Uti
18. Ulinastatin [inn:jan]
19. Trypsin Inhibitor, Mingin
20. Trypsin Inhibitor, Bikunin
21. Urinary Trypsin Inhibitor 1
22. 3-(2-furanyl)-2,4-dioxaspiro(5.5)undec-8-ene
23. Dtxsid801001247
24. Bcp08067
25. Akos025401879
26. Ac-26827
27. Hy-21646
28. D77201
29. 9-(2-furyl)-8,10-dioxaspiro[5.5]undec-3-ene
Molecular Weight | 220.26 g/mol |
---|---|
Molecular Formula | C13H16O3 |
XLogP3 | 2.1 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 1 |
Exact Mass | 220.109944368 g/mol |
Monoisotopic Mass | 220.109944368 g/mol |
Topological Polar Surface Area | 31.6 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 266 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Trypsin Inhibitors
Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds. (See all compounds classified as Trypsin Inhibitors.)
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
82
PharmaCompass offers a list of Urinastatin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Urinastatin manufacturer or Urinastatin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Urinastatin manufacturer or Urinastatin supplier.
PharmaCompass also assists you with knowing the Urinastatin API Price utilized in the formulation of products. Urinastatin API Price is not always fixed or binding as the Urinastatin Price is obtained through a variety of data sources. The Urinastatin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)-, including repackagers and relabelers. The FDA regulates 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- supplier is an individual or a company that provides 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- active pharmaceutical ingredient (API) or 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- finished formulations upon request. The 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- suppliers may include 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- API manufacturers, exporters, distributors and traders.
click here to find a list of 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- Drug Master File in Korea (2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)-. The MFDS reviews the 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- KDMF as part of the drug registration process and uses the information provided in the 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- KDMF to evaluate the safety and efficacy of the drug.
After submitting a 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- suppliers with KDMF on PharmaCompass.
A 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- written confirmation (2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- WC) is an official document issued by a regulatory agency to a 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- manufacturer, verifying that the manufacturing facility of a 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- APIs or 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- finished pharmaceutical products to another nation, regulatory agencies frequently require a 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- WC (written confirmation) as part of the regulatory process.
click here to find a list of 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- suppliers with Written Confirmation (WC) on PharmaCompass.
2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- GMP manufacturer or 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- GMP API supplier for your needs.
A 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- CoA (Certificate of Analysis) is a formal document that attests to 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)-'s compliance with 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- specifications and serves as a tool for batch-level quality control.
2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- CoA mostly includes findings from lab analyses of a specific batch. For each 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- may be tested according to a variety of international standards, such as European Pharmacopoeia (2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- EP), 2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- JP (Japanese Pharmacopeia) and the US Pharmacopoeia (2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)- USP).